In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolated from patients with cystic fibrosis

In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020

(2022) James A. Karlowsky et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New Perspectives on Antimicrobial Agents: Imipenem-Relebactam

(2022) J. Nicholas O’Donnell et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)

(2022) Marta Hernández-García et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosis

(2021) Maxwell J. Lasko et al.   Annals of Clinical Microbiology and Antimicrobials

Imipenem‐Cilastatin‐Relebactam: A Novel β‐Lactam–β‐Lactamase Inhibitor Combination for the Treatment of Multidrug‐Resistant Gram‐Negative Infections

(2020) Jordan R. Smith et al.   PHARMACOTHERAPY

A Critical Evaluation of Newer β-Lactam Antibiotics for Treatment of Pseudomonas aeruginosa Infections

(2020) Kathleen C. Blomquist et al.   ANNALS OF PHARMACOTHERAPY

Cystic Fibrosis and Pseudomonas aeruginosa: the Host-Microbe Interface

(2019) Sankalp Malhotra et al.   CLINICAL MICROBIOLOGY REVIEWS

Carbapenem Non-susceptible Pseudomonas aeruginosa from Intensive Care Units in the United States: A Potential Role for New β-lactam Combination Agents

(2019) Tomefa E Asempa et al.   JOURNAL OF CLINICAL MICROBIOLOGY

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa

(2019) Katherine Young et al.   BMC MICROBIOLOGY

Activity of Imipenem with Relebactam against Gram-Negative Pathogens from New York City

(2015) Amabel Lapuebla et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Management ofPseudomonas aeruginosainfection in cystic fibrosis patients using inhaled antibiotics with a focus on nebulized liposomal amikacin

(2015) Zarmina Ehsan et al.   Future Microbiology